Table 1.
Parameters | Cmax (ng/mL) | Tmax (h) | AUC (ng/mL·h) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Dose | Population | Pre 3 | Obs 4 | FE 5 | Pre | Obs | FE | Pre | Obs | FE |
1 mg | Exp 1 (n = 16) | 5.74 | 3.88 | 1.48 | 1.08 | 1.75 | 1.61 | 22.50 | 19.34 | 1.16 |
Non-exp 2 (n = 26) | 9.93 | 5.52 | 1.80 | 1.08 | 1.5 | 1.38 | 37.47 | 30.34 | 1.24 | |
2 mg | Exp (n = 31) | 14.50 | 14.09 | 1.03 | 1.08 | 1.26 | 1.16 | 71.53 | 60.83 | 1.18 |
Non-exp (n = 40) | 23.87 | 24.28 | 1.02 | 1.08 | 1.35 | 1.25 | 102.54 | 119.02 | 1.16 | |
5 mg | Exp (n = 12) | 21.41 | 20.8 | 1.03 | 0.84 | 1.40 | 1.67 | 131.07 | 90.40 | 1.45 |
Non-exp (n = 12) | 36.73 | 27.90 | 1.32 | 0.84 | 1.30 | 1.55 | 227.07 | 134.77 | 1.68 |
1 Exp: CYP3A5 expressers; 2 Non-exp: CYP3A5 non-expressers; 3 Pre: Predicted; 4 Obs: Observed; 5 FE: Fold error.